Trade Vericel Corp - VCEL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.21 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023429% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001207% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 39.38 |
| Open | 40.68 |
| 1-Year Change | -10.16% |
| Day's Range | 40.29 - 41.74 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 22, 2025 | 39.38 | -0.84 | -2.09% | 40.22 | 41.61 | 39.22 |
| Apr 21, 2025 | 40.82 | 0.58 | 1.44% | 40.24 | 41.69 | 40.12 |
| Apr 17, 2025 | 41.19 | 0.69 | 1.70% | 40.50 | 41.48 | 40.33 |
| Apr 16, 2025 | 40.74 | -0.28 | -0.68% | 41.02 | 41.87 | 39.67 |
| Apr 15, 2025 | 41.94 | 1.35 | 3.33% | 40.59 | 42.22 | 40.45 |
| Apr 14, 2025 | 41.10 | 0.58 | 1.43% | 40.52 | 42.27 | 40.52 |
| Apr 11, 2025 | 41.15 | 1.00 | 2.49% | 40.15 | 41.64 | 39.37 |
| Apr 10, 2025 | 41.88 | -0.24 | -0.57% | 42.12 | 42.79 | 40.25 |
| Apr 9, 2025 | 44.17 | 6.46 | 17.13% | 37.71 | 44.47 | 37.71 |
| Apr 8, 2025 | 38.54 | -1.74 | -4.32% | 40.28 | 40.54 | 37.69 |
| Apr 7, 2025 | 39.84 | -0.12 | -0.30% | 39.96 | 42.31 | 38.43 |
| Apr 4, 2025 | 41.79 | -0.46 | -1.09% | 42.25 | 42.97 | 41.00 |
| Apr 3, 2025 | 43.42 | 1.86 | 4.48% | 41.56 | 44.28 | 41.56 |
| Apr 2, 2025 | 44.26 | 1.83 | 4.31% | 42.43 | 44.75 | 42.38 |
| Apr 1, 2025 | 43.02 | -0.94 | -2.14% | 43.96 | 44.21 | 42.49 |
| Mar 31, 2025 | 44.51 | 1.22 | 2.82% | 43.29 | 44.63 | 42.48 |
| Mar 28, 2025 | 44.41 | -0.84 | -1.86% | 45.25 | 45.71 | 44.04 |
| Mar 27, 2025 | 45.90 | -0.49 | -1.06% | 46.39 | 46.50 | 45.32 |
| Mar 26, 2025 | 46.35 | -1.08 | -2.28% | 47.43 | 47.43 | 46.04 |
| Mar 25, 2025 | 47.91 | 0.63 | 1.33% | 47.28 | 48.47 | 47.06 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Vericel Corp Ord Company profile
About Vericel Corp
Vericel Corporation is a commercial-stage biopharmaceutical company. The Company specializes in cell therapies and specialty biologics for the sports medicine and severe burn care. It operates in one reportable segment, the research, product development, manufacture, and distribution of cellular therapies for use in the treatment of specific diseases. It markets two autologous cell therapy products in the United States, which includes MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The MACI is an autologous cellularized scaffold product indicated for the repair of symptomatic, single, or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. The Epicel is a permanent skin replacement humanitarian use device (HUD) for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area (TBSA).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Vericel Corp revenues increased 26% to $156.2M. Net loss totaled $7.5M vs. income of $2.9M. Revenues reflect MACI segment increase of 18% to $111.6M, Epicel segment increase of 51% to $41.5M. Net loss reflects Stock-based Compensation in SGA increase from $10M to $26.5M (expense), Other Selling , General Expense increase of 21% to $71.1M (expense).
Equity composition
Common Stock no Par, 3/11, 62.5M auth., 38,618,037 issd. Insiders control approx. 0.63%. IPO: 2/97, 3M shares @ $7 byCowen & Company. 02/10 1-for-8 reverse split. 10/13, 1-for-20 Reverse Stock split.
| Industry: | Biopharmaceuticals |
64 Sidney St
CAMBRIDGE
MASSACHUSETTS 02139-4170
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com